文献速递消化内镜消化道肿瘤与早癌

基线计算机辅助检测结肠镜检查后高危患者的监测结果:一项倾向性评分匹配分析

Surveillance findings in high-risk patients after baseline computer-assisted detection colonoscopy: a propensity score matching analysis.
PubMed 文献 · Gastrointest Endosc · 2025-02-04

本研究比较基线使用计算机辅助检测(CADe)与传统检测的高危病变患者监测结肠镜检查结果,经倾向性评分1:2匹配后纳入162例。基线使用CADe者监测时进展期腺瘤检出率(11.1% vs 24.1%,P=.05)及每次结肠镜进展期腺瘤数(0.1 vs 0.3,P=.01)均显著低于传统结肠镜者,腺瘤检出率(44.4% vs 63.0%,P=.02)及每次结肠镜腺瘤数(0.6 vs 1.2,P=.01)也呈类似模式。基线使用CADe者发生任何异时性腺瘤或锯齿状病变的累积发生率显著低于传统结肠镜者(log rank P=.05)。

要点

  • 基线CADe组监测结肠镜进展期腺瘤检出率11.1% vs 传统组24.1%(P=.05)
  • 基线CADe组每次结肠镜进展期腺瘤数0.1 vs 传统组0.3(P=.01)
  • 基线CADe组异时性腺瘤或锯齿状病变累积发生率显著更低(log rank P=.05)

核心结论

  • 基线结肠镜检查使用CADe的患者在监测结肠镜检查时异时性病变(包括进展期腺瘤)的发生率显著低于基线使用传统检测的患者。

研究设计与样本

  • 纳入基线存在高危病变(进展期腺瘤、进展期锯齿状病变或基线结肠镜发现3个及以上腺瘤)并接受监测结肠镜检查的患者。
  • 按基线是否使用CADe(对比传统检测)分为2组,以1:2比例按监测间隔、基线特征和指数结肠镜检查发现进行倾向性评分匹配(PSM)。
  • 403例高危基线病变且接受监测结肠镜检查的患者中,经PSM后162例被纳入分析。
  • 主要结局为异时性进展期腺瘤(AA)发生率。

主要发现

  • 基线使用CADe者进展期腺瘤检出率为11.1%,传统结肠镜者为24.1%(P=.05),CADe组显著低于传统组。
  • 基线使用CADe者每次结肠镜进展期腺瘤数为0.1,传统结肠镜者为0.3(P=.01),CADe组显著低于传统组。
  • 基线使用CADe者腺瘤检出率为44.4%,传统结肠镜者为63.0%(P=.02),CADe组显著低于传统组。
  • 基线使用CADe者每次结肠镜检出腺瘤数为0.6,传统结肠镜者为1.2(P=.01),CADe组显著低于传统组。
  • 基线使用CADe者发生任何异时性腺瘤或锯齿状病变的累积发生率显著低于传统结肠镜者(log rank P=.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The impact of computer-assisted detection (CADe) on surveillance colonoscopy findings remains unknown. We compare surveillance colonoscopy findings in patients with high-risk lesions detected at baseline, with or without the application of CADe. METHODS: We included patients with high-risk baseline lesions who had undergone surveillance colonoscopy. High-risk baseline lesions included advanced adenoma, advanced serrated lesion, or 3 or more adenomas at baseline colonoscopy. Patients were divided into 2 groups according to baseline use of CADe (vs conventional detection), and matched by propensity score matching (PSM) in a 1:2 ratio for surveillance interval, baseline characteristics, and index colonoscopy findings. The primary outcome was metachronous advanced adenoma (AA) rate. RESULTS: Of 403 patients with high-risk baseline lesions and surveillance colonoscopy, 162 were included after PSM. In patients with baseline use of CADe, both the advanced adenoma detection rate (11.1% vs 24.1%; P = .05) and the number of advanced adenomas per colonoscopy (0.1 vs 0.3; P = .01) were significantly lower than in those with conventional colonoscopy. Similar pattern was observed for the adenoma detection rate (44.4% vs 63.0%; P = .02) and the number of adenomas detected per colonoscopy (0.6 vs 1.2; P = .01). The cumulative incidence of patients with any metachronous adenoma or serrated lesion was significantly lower in patients with baseline use of CADe than in those with conventional colonoscopy (log rank P = .05). CONCLUSIONS: Patients who had CADe use at baseline colonoscopy had significantly lower rates of metachronous lesions, including advanced adenomas, on surveillance colonoscopy.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Lui TKL, Ko MKL, To EWP, et al. Surveillance findings in high-risk patients after baseline computer-assisted detection colonoscopy: a propensity score matching analysis. Gastrointest Endosc. 2025. PMID: 39914631. doi:10.1016/j.gie.2025.01.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。